Standard BioTools Inc.

DB:FLB Stock Report

Market Cap: €722.7m

Standard BioTools Future Growth

Future criteria checks 1/6

Standard BioTools is forecast to grow earnings and revenue by 57.9% and 14.7% per annum respectively. EPS is expected to grow by 64.1% per annum. Return on equity is forecast to be -11.9% in 3 years.

Key information

57.9%

Earnings growth rate

64.1%

EPS growth rate

Life Sciences earnings growth26.4%
Revenue growth rate14.7%
Future return on equity-11.9%
Analyst coverage

Low

Last updated31 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:FLB - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026229-33-9-12
12/31/2025188-84-69-623
12/31/2024171-155-164-1573
9/30/2024156-171-149-143N/A
6/30/2024136-165-131-127N/A
3/31/2024127-136-100-97N/A
12/31/2023106-75-46-43N/A
9/30/2023105-76-52-48N/A
6/30/2023105-84-65-62N/A
3/31/202397-131-86-82N/A
12/31/202298-190-93-89N/A
9/30/2022109-179-81-77N/A
6/30/2022112-163-66-62N/A
3/31/2022124-117-54-47N/A
12/31/2021131-59-57-44N/A
9/30/2021137-68-64-41N/A
6/30/2021148-60-58-36N/A
3/31/2021143-56-43-24N/A
12/31/2020138-53-28-15N/A
9/30/2020126-48-20-17N/A
6/30/2020113-55-21-17N/A
3/31/2020115-55-23-19N/A
12/31/2019117-65-38-35N/A
9/30/2019117-67-32-30N/A
6/30/2019120-69-31-30N/A
3/31/2019118-71-30-29N/A
12/31/2018113-59-26-25N/A
9/30/2018108-55-24-24N/A
6/30/2018104-56N/A-28N/A
3/31/2018102-57N/A-32N/A
12/31/2017102-61N/A-24N/A
9/30/201799-68N/A-35N/A
6/30/201797-72N/A-41N/A
3/31/2017101-73N/A-40N/A
12/31/2016104-76N/A-39N/A
9/30/2016110-71N/A-33N/A
6/30/2016117-61N/A-32N/A
3/31/2016117-57N/A-33N/A
12/31/2015115-53N/A-35N/A
9/30/2015117-51N/A-34N/A
6/30/2015118-56N/A-30N/A
3/31/2015117-53N/A-22N/A
12/31/2014116-53N/A-23N/A
9/30/2014104-47N/A-16N/A
6/30/201492-37N/A-8N/A
3/31/201482-28N/A-11N/A
12/31/201371-17N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: FLB is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: FLB is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: FLB is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: FLB's revenue (14.7% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: FLB's revenue (14.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: FLB is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y